Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia.
Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia. J Pharm Sci. 2018 02; 107(2):638-646.
View in:
PubMed
subject areas
Administration, Intravaginal
Administration, Intravaginal
Animals
Animals
Biological Availability
Biological Availability
Chemistry, Pharmaceutical
Chemistry, Pharmaceutical
Chromans
Chromans
Cyclin D1
Cyclin D1
Drug Delivery Systems
Drug Delivery Systems
Female
Female
Humans
Humans
Mice
Mice
Quality of Life
Quality of Life
Suppositories
Suppositories
Thiones
Thiones
Uterine Cervical Dysplasia
Uterine Cervical Dysplasia
authors with profiles
Doris M Benbrook
Lucila Garcia-Contreras
Vishal Chandra